Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway
- PMID: 16357307
- DOI: 10.1161/01.RES.0000200178.34179.93
Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway
Abstract
beta-Adrenergic signaling via cAMP generation and PKA activation mediates the positive inotropic effect of catecholamines on heart cells. Given the large diversity of protein kinase A targets within cardiac cells, a precisely regulated and confined activity of such signaling pathway is essential for specificity of response. Phosphodiesterases (PDEs) are the only route for degrading cAMP and are thus poised to regulate intracellular cAMP gradients. Their spatial confinement to discrete compartments and functional coupling to individual receptors provides an efficient way to control local [cAMP]i in a stimulus-specific manner. By performing real-time imaging of cyclic nucleotides in living ventriculocytes we identify a prominent role of PDE2 in selectively shaping the cAMP response to catecholamines via a pathway involving beta3-adrenergic receptors, NO generation and cGMP production. In cardiac myocytes, PDE2, being tightly coupled to the pool of adenylyl cyclases activated by beta-adrenergic receptor stimulation, coordinates cGMP and cAMP signaling in a novel feedback control loop of the beta-adrenergic pathway. In this, activation of beta3-adrenergic receptors counteracts cAMP generation obtained via stimulation of beta1/beta2-adrenoceptors. Our study illustrates the key role of compartmentalized PDE2 in the control of catecholamine-generated cAMP and furthers our understanding of localized cAMP signaling.
Similar articles
-
Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.J Mol Cell Cardiol. 2016 Feb;91:215-27. doi: 10.1016/j.yjmcc.2016.01.004. Epub 2016 Jan 7. J Mol Cell Cardiol. 2016. PMID: 26773602 Free PMC article.
-
Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.Cardiovasc Res. 2015 Jun 1;106(3):408-20. doi: 10.1093/cvr/cvv123. Epub 2015 Apr 7. Cardiovasc Res. 2015. PMID: 25852085
-
Phosphodiesterases and compartmentalized cAMP signalling in the heart.Eur J Cell Biol. 2006 Jul;85(7):693-7. doi: 10.1016/j.ejcb.2006.01.002. Epub 2006 Feb 7. Eur J Cell Biol. 2006. PMID: 16466668 Review.
-
Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.J Mol Cell Cardiol. 2015 Nov;88:29-38. doi: 10.1016/j.yjmcc.2015.09.011. Epub 2015 Sep 23. J Mol Cell Cardiol. 2015. PMID: 26388264 Free PMC article.
-
cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology.Circ Res. 2007 Jun 8;100(11):1569-78. doi: 10.1161/CIRCRESAHA.106.144501. Circ Res. 2007. PMID: 17556670 Review.
Cited by
-
Distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium.PLoS One. 2012;7(10):e47652. doi: 10.1371/journal.pone.0047652. Epub 2012 Oct 15. PLoS One. 2012. PMID: 23077656 Free PMC article.
-
Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays.Biochem J. 2007 May 15;404(1):71-80. doi: 10.1042/BJ20070005. Biochem J. 2007. PMID: 17288540 Free PMC article.
-
Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells.Br J Pharmacol. 2011 May;163(2):261-71. doi: 10.1111/j.1476-5381.2010.01107.x. Br J Pharmacol. 2011. PMID: 21054345 Free PMC article.
-
Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure.Cardiovasc Drugs Ther. 2020 Jun;34(3):401-417. doi: 10.1007/s10557-020-06959-1. Cardiovasc Drugs Ther. 2020. PMID: 32172427 Free PMC article. Review.
-
Message delivered: how myocytes control cAMP signaling.Circ Res. 2008 May 9;102(9):1002-4. doi: 10.1161/CIRCRESAHA.108.176420. Circ Res. 2008. PMID: 18467638 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases